Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Other Accumulated Expenses (2016 - 2020)

Historic Other Accumulated Expenses for Rockwell Medical (RMTI) over the last 10 years, with Q1 2020 value amounting to $57000.0.

  • Rockwell Medical's Other Accumulated Expenses fell 9775.21% to $57000.0 in Q1 2020 from the same period last year, while for Mar 2020 it was $57000.0, marking a year-over-year decrease of 9775.21%. This contributed to the annual value of $104000.0 for FY2019, which is 7504.01% down from last year.
  • Latest data reveals that Rockwell Medical reported Other Accumulated Expenses of $57000.0 as of Q1 2020, which was down 9775.21% from $104000.0 recorded in Q4 2019.
  • Rockwell Medical's 5-year Other Accumulated Expenses high stood at $2.5 million for Q1 2019, and its period low was $57000.0 during Q1 2020.
  • Its 5-year average for Other Accumulated Expenses is $1.3 million, with a median of $1.6 million in 2018.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first soared by 18457.84% in 2019, then plummeted by 9775.21% in 2020.
  • Rockwell Medical's Other Accumulated Expenses (Quarter) stood at $2.0 million in 2016, then grew by 15.4% to $2.3 million in 2017, then crashed by 82.07% to $416668.0 in 2018, then crashed by 75.04% to $104000.0 in 2019, then crashed by 45.19% to $57000.0 in 2020.
  • Its last three reported values are $57000.0 in Q1 2020, $104000.0 for Q4 2019, and $1.9 million during Q3 2019.